Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB
Mandate

Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB

March 02, 2016

Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB in connection with the acquistion of Lidköping Biogas AB. Lidköping Biogas produces liquid biogas for inter alia trucks and has an annual capacity of 60 GWh.

FordonsGas operates and builds gas tank stations in Sweden, and currenly operates more than 40 gas tank stations, predominantly in the western part of Sweden. Through the acquisition of Lidköping Biogas, FordonsGas Sverige will get an even better control over the production chain and can further develop sustainable mobility.

The Vinge team advising Air Liquide Advanced Business S.A./FordonsGas Sverige AB consists of Jesper Ottergren together with Anna Edström and, inter alia, Christoffer Thalin, Mathias Lindquist, Emma Hakesjö and Cecilia Cronquist.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025